Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance

Tuberculosis

Volumn 92, Issue 1, 2012, Pages 84-91

  Zimic, Mirko ^a   Fuentes, Patricia ^a   Gilman, Robert H ^a,b   Gutiérrez, Andrés H ^a   Kirwan, Daniela ^c   Sheen, Patricia ^a  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Mycobacterium tuberculosis; POA efflux rate; PZA flux rate; PZA resistance

Indexed keywords

BACTERIAL PROTEIN; ENZYME; PNCA PROTEIN; PYRAZINAMIDASE; PYRAZINAMIDE; PYRAZINOIC ACID; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; ENZYME ACTIVITY; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PUBLIC HEALTH; PYRAZINAMIDE;

EID: 84856454635     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2011.09.002     Document Type: Article

References (31)

1. E.L. Corbett, C.J. Watt, N. Walker, D. Maher, B.G. Williams, M.C. Raviglione, and C. Dye The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch Intern Med 163 2003 1009 1021 (Pubitemid 36548927)
2. B.R. Bloom, and C.J. Murray Tuberculosis: commentary on a reemergent killer Science 257 1992 1055 1064
3. K. Konno, F.M. Feldmann, and W. McDermott Pyrazinamide susceptibility and amidase activity of tubercle bacilli Am Rev Respir Dis 95 1967 461 469
4. D.A. Mitchison The action of antituberculosis drugs in short-course chemotherapy Tubercle 66 1985 219 225 (Pubitemid 16150082)
5. M.A. Steele, and R.M. Des Prez The role of pyrazinamide in tuberculosis chemotherapy Chest 94 1988 845 850
6. L. Vasquez-Campos, L. Asencios-Solis, E. Leo-Hurtado, N. Quispe-Torres, E. Salazar-Lindo, J. Bayona, and M.C. Becerra Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001 Int J Tuberc Lung Dis 8 2004 465 472 (Pubitemid 38624856)
7. J.K. McClatchy, A.Y. Tsang, and M.S. Cernich Use of pyrazinamidase activity on Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility Antimicrob Agents Chemother 20 1981 556 557 (Pubitemid 12239277)
8. M. Salfinger, and L.B. Heifets Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method Antimicrob Agents Chemother 32 1988 1002 1004
9. T.J. Brown, O. Tansel, and G.L. French Simultaneous identification and typing of multi-drug-resistant Mycobacterium tuberculosis isolates by analysis of pncA and rpoB J Med Microbiol 49 2000 651 656 (Pubitemid 30447280)
10. M.T. McCammon, J.S. Gillette, D.P. Thomas, S.V. Ramaswamy, Rosas II, E.A. Graviss, J. Vijg, and T.N. Quitugua Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region Antimicrob Agents Chemother 49 2005 2210 2217 (Pubitemid 40734447)
11. P. Sheen, M. Mendez, R.H. Gilman, L. Pena, L. Caviedes, M.J. Zimic, Y. Zhang, D.A. Moore, and C.A. Evans Sputum PCR-single-strand conformational polymorphism test for same-day detection of pyrazinamide resistance in tuberculosis patients J Clin Microbiol 47 2009 2937 2943
12. S.J. Cheng, L. Thibert, T. Sanchez, L. Heifets, and Y. Zhang pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada Antimicrob Agents Chemother 44 2000 528 532 (Pubitemid 30117936)
13. Y. Zhang, and D. Mitchison The curious characteristics of pyrazinamide: a review Int J Tuberc Lung Dis 7 2003 6 21 (Pubitemid 36427026)
14. A. Scorpio, P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and Y. Zhang Characterization of pncA mutations in pyrazinamide- resistant Mycobacterium tuberculosis Antimicrob Agents Chemother 41 1997 540 543 (Pubitemid 27098400)
15. Y. Zhang, M.M. Wade, A. Scorpio, H. Zhang, and Z. Sun Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid J Antimicrob Chemother 52 2003 790 795 (Pubitemid 37407806)
16. Z. Sun, and Y. Zhang Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide Antimicrob Agents Chemother 43 1999 537 542 (Pubitemid 29109516)
17. Y. Zhang, A. Scorpio, H. Nikaido, and Z. Sun Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide J Bacteriol 181 1999 2044 2049 (Pubitemid 29164956)
18. P. Sheen, P. Ferrer, R.H. Gilman, J. Lopez-Llano, P. Fuentes, E. Valencia, and M.J. Zimic Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis Tuberculosis (Edinb) 89 2009 109 113
19. S.S. Trivedi, and S.G. Desai Pyrazinamidase activity of Mycobacterium tuberculosis-a test of sensitivity to pyrazinamide Tubercle 68 1987 221 224 (Pubitemid 18012661)
20. M.M. Wade, and Y. Zhang Mechanisms of drug resistance in Mycobacterium tuberculosis Front Biosci 9 2004 975 994 (Pubitemid 39043767)
21. M. Mestdagh, P.A. Fonteyne, L. Realini, R. Rossau, G. Jannes, W. Mijs, K.A. De Smet, F. Portaels, and E. Van den Eeckhout Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis Antimicrob Agents Chemother 43 1999 2317 2319 (Pubitemid 29421225)
22. W.R. Butler, and J.O. Kilburn Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity Antimicrob Agents Chemother 24 1983 600 601 (Pubitemid 13021442)
23. Y. Suzuki, A. Suzuki, A. Tamaru, C. Katsukawa, and H. Oda Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system J Clin Microbiol 40 2002 501 507 (Pubitemid 34130874)
24. N. Lemaitre, W. Sougakoff, C. Truffot-Pernot, and V. Jarlier Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA Antimicrob Agents Chemother 43 1999 1761 1763 (Pubitemid 29331263)
25. L. McMurry, R.E. Petrucci Jr., and S.B. Levy Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli Proc Natl Acad Sci U S A 77 1980 3974 3977 (Pubitemid 10022532)
26. J. Liu, H.E. Takiff, and H. Nikaido Active Efflux of Fluoroquinolones in Mycobacterium smegmatis Mediated by LfrA, a Multidrug Efflux Pump J Bacteriol 178 1996 3791 3795 (Pubitemid 26227194)
27. H. Okusu, D. Ma, and H. Nikaido AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic- resistance (Mar) mutants J Bacteriol 178 1996 306 308 (Pubitemid 26006095)
28. P.T.K.B. Kent Public health mycobacteriology: a guide for the level III laboratory 1985 USDHHS: Centers for Disease Control Atlanta
29. L.G. Wayne Simple pyrazinamidase and urease tests for routine identification of mycobacteria Am Rev Respir Dis 109 1974 147 151
30. X. Du, W. Wang, R. Kim, H. Yakota, H. Nguyen, and S.H. Kim Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii Biochemistry 40 2001 14166 14172 (Pubitemid 33081619)
31. W. Shi, X. Zhang, X. Jiang, H. Yuan, J.S. Lee, C.E. Barry 3rd, H. Wang, W. Zhang, and Y. Zhang Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis Science 2011